
SB 203580 hydrochloride NEW
Price | $36 | $54 | $85 |
Package | 5mg | 10mg | 25mg |
Min. Order: | |
Supply Ability: | 10g |
Update Time: | 2024-11-15 |
Product Details
Product Name: SB 203580 hydrochloride | CAS No.: 869185-85-3 |
Supply Ability: 10g | Release date: 2024/11/15 |
Product Introduction
Bioactivity
名稱 | SB 203580 hydrochloride |
描述 | SB 203580 hydrochloride (Adezmapimod hydrochloride) is a selective, ATP-competitive p38 MAPK inhibitor that induces mitochondrial autophagy and cytosolic autophagy and inhibits SAPK2a/p38, SAPK2b/p38β2, LCK, GSK3β, and PKBα. SB 203580 hydrochloride has been shown to be useful in antiretroviral therapy. 203580 hydrochloride inhibits amphoteric mechanical anomalous pain in a mouse model of antiretroviral-induced neuropathic pain. |
體外活性 | SB 203580 hydrochloride is a selective ATP-competitive p38 MAPK inhibitor against SAPK2a/p38 IC50=50 nM and SAPK2b/p38β2 IC50=500 nM. [1] 0-30 μM SB 203580 hydrochloride pre-incubation, 1 hr and incubation in the presence of 20 ng/mL IL-2 for 24 hr was able to inhibit the IL-2-induced proliferation of primary human T cells, mouse CT6 T cells, or BAF F7 B cells with IC50 values of 3-5 μM. [2] SB 203580 hydrochloride blocks the phosphorylation of PKB (protein kinase B) with an IC50 of approximately 5 μM. [2] |
體內(nèi)活性 | An exogenous tumor model in female thymus-free Nu/Nu mice, 5 mg/kg/day SB 203580 hydrochloride, was injected intraperitoneally daily for 16 consecutive days, and the tumors in the p38WT group were significantly smaller than those in the p38TM tumors of the parallel treatments after treatment. [3] |
存儲(chǔ)條件 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度 | H2O : 2 mg/mL(4.83 mM), Sonication is recommended. DMSO : 80 mg/mL(193.28 mM), Sonication is recommended. |
關(guān)鍵字 | SB-203580 Hydrochloride |
相關(guān)產(chǎn)品 | Nintedanib | Exarafenib | Doramapimod | Vemurafenib | Staurosporine | Bakuchiol | Ibrutinib | Dasatinib | Ponatinib | SB 202190 | (-)-Bornyl acetate | MW-150 |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$2980.00/50mg |
VIP1Y
|
TargetMol Chemicals Inc.
|
2024-10-28 | |
$46.00/2mg |
VIP3Y
|
TargetMol Chemicals Inc.
|
2024-10-23 | |
$1.00/1KG |
VIP5Y
|
Career Henan Chemica Co
|
2020-10-29 |
- Since: 2011-01-07
- Address: 36?Washington?Street, Wellesley?Hills
INQUIRY